Frog Microbes May Help Fight Disease

Commensal skin bacteria adjusted their community structure when frogs were exposed to chytrid fungus in a recent study.

Written byKaren Zusi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

VIRGINIA TECHChytridiomycosis, a skin disease caused by the chytrid fungus Batrachochytrium dendrobatidis, currently threatens approximately 500 amphibian species worldwide. Researchers led by a team from Virginia Tech demonstrated that the composition of microbes on bullfrogs’ skin can indirectly affect the disease symptoms; the results were published today (October 7) in PLOS ONE.

Researchers at Virginia Tech and their colleagues collected 60 juvenile bullfrogs (Lithobates catesbieanus) from a pond in Virginia where the fungus had previously been detected. The team sampled the frogs’ naturally occurring skin microbes and randomly assigned them to one of six experimental groups: the frogs’ skin microbiomes were either reduced with antibiotics, augmented with a probiotic, or left alone. The bullfrogs were then either exposed to the fungus or used as a control over the 42-day experiment.

When the researchers analyzed the resulting microbial communities on the frogs, they discovered that simply augmenting or reducing the skin microbiome did not affect the intensity of the fungal infection—but the antibiotic-treated frogs grew less than their counterparts when exposed to the fungus. The microbes differed in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies